Recent GWAS findings have indicated that variants of the IRF4 gene were associated with the susceptibility to some cancer types, including CLL, HL, NHL, MM and skin cancer [25-27,35]. Here, IRF4 is linked to B-cell chronic lymphocytic leukemia.